SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 59 filers reported holding SUTRO BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,152,000 | -70.1% | 148,400 | -56.2% | 0.34% | -63.9% |
| Q2 2019 | $3,858,000 | -15.1% | 339,059 | -15.0% | 0.93% | -24.1% |
| Q1 2019 | $4,542,000 | +78.6% | 398,796 | +41.5% | 1.23% | +32.4% |
| Q4 2018 | $2,543,000 | -27.1% | 281,914 | +21.2% | 0.93% | -22.6% |
| Q3 2018 | $3,488,000 | – | 232,539 | – | 1.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |